Cerus Corp.

Cerus Corp. develops and sells the INTERCEPT Blood System—proprietary technology that inactivates pathogens in platelets, plasma, red cells, and cryoprecipitate—serving global transfusion markets and driving safety and revenue growth.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 614
HQ: Concord

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CERS	Cerus Corp. Cap: 0.4B	EQUITY	NGM	USD	US1570851014	Active	📈